If someone becomes pregnant while taking a GLP-1, the key is not to panic, but to stop the medication and talk with a clinician about the safest path forward for both parent and baby
Women over 40 and in perimenopause or menopause This demographic is at highest risk for GLP-1 related hair loss
In addition, Lilly has reported data suggesting that patients transitioning from injectable incretin therapies to oral GLP-1 treatment were able to maintain weight loss in late-stage studies
If approved, the program connects patients with a partner pharmacy that prepares and ships the prescribed medication directly to their home
24% are getting more matches
For subjects treated with the highest dose of tirzepatide (15 mg per week), the risk to develop any major adverse cardiovascular event (MACE-4 composed of myocardial infarction, stroke, hospitalization for angina, and all-cause death) was estimated at 050 (026095)